Adaptive Biotechnologies Corporation

ADPT · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income$10-$26-$30-$34
Dep. & Amort.$4$5$5$4
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$13$0$13
Change in WC-$34-$5-$16$3
Other Non-Cash$13$1$13$1
Operating Cash Flow-$7-$12-$28-$12
Investing Activities
PP&E Inv.-$0-$1-$1-$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$33-$51-$51-$45
Inv. Sales/Matur.$51$55$77$67
Other Inv. Act.$0$0$0$0
Investing Cash Flow$17$3$26$22
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$2$2$5$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$2$2$5$0
Forex Effect$0$0$0$0
Net Chg. in Cash$12-$7$3$10
Supplemental Information
Beg. Cash$43$53$48$41
End Cash$55$46$51$51
Free Cash Flow-$8-$13-$30-$13
Adaptive Biotechnologies Corporation (ADPT) Financial Statements & Key Stats | AlphaPilot